MannKind Corp (MNKD)
6.84
-0.06
(-0.87%)
USD |
NASDAQ |
Nov 22, 16:00
6.93
+0.09
(+1.32%)
Pre-Market: 09:09
MannKind Revenue (Quarterly): 70.08M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 70.08M |
| June 30, 2024 | 72.39M |
| March 31, 2024 | 66.26M |
| December 31, 2023 | 58.47M |
| September 30, 2023 | 51.25M |
| June 30, 2023 | 48.61M |
| March 31, 2023 | 40.63M |
| December 31, 2022 | 36.06M |
| September 30, 2022 | 32.82M |
| June 30, 2022 | 18.89M |
| March 31, 2022 | 11.99M |
| December 31, 2021 | 12.52M |
| September 30, 2021 | 22.21M |
| June 30, 2021 | 23.28M |
| March 31, 2021 | 17.44M |
| December 31, 2020 | 18.44M |
| September 30, 2020 | 15.35M |
| June 30, 2020 | 15.11M |
| March 31, 2020 | 16.24M |
| December 31, 2019 | 15.99M |
| September 30, 2019 | 14.60M |
| June 30, 2019 | 15.00M |
| March 31, 2019 | 17.45M |
| December 31, 2018 | 16.03M |
| September 30, 2018 | 4.469M |
| Date | Value |
|---|---|
| June 30, 2018 | 3.893M |
| March 31, 2018 | 3.465M |
| December 31, 2017 | 4.53M |
| September 30, 2017 | 2.043M |
| June 30, 2017 | 2.163M |
| March 31, 2017 | 3.009M |
| December 31, 2016 | 12.40M |
| September 30, 2016 | 162.35M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | 0.035M |
| June 30, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
11.99M
Minimum
Mar 2022
72.39M
Maximum
Jun 2024
33.20M
Average
22.75M
Median
Revenue (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 90.38M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.55M |
| Total Expenses (Quarterly) | 54.86M |
| EPS Diluted (Quarterly) | 0.04 |
| Enterprise Value | 1.863B |
| Gross Profit Margin (Quarterly) | 74.28% |
| Profit Margin (Quarterly) | 16.48% |
| Earnings Yield | 1.17% |
| Operating Earnings Yield | 2.91% |
| Normalized Earnings Yield | 1.486 |